Literature DB >> 1170215

Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man.

R J Pepperell, D M Kretser, H G Burger.   

Abstract

The metabolic clearance rate (MCR) of human luteinizing hormone (hLH) has been determined in 10 normal men, 3 normal women, and in 12 women with ovulatory disorders resulting in oligomenorrhea or amenorrhea. The MCR was determined by the constant infusion technique using either iodinated or unlabeled highly purified hLH, and these results were compared to MCR determined by using crude pituitary preparations containing both follicle-stimulating hormone and hLH. Both preparations produced essentially similar results for the MCR of hLH and virtually identical results were obtained when complete or incomplete immunoprecipitation of the infused material was achieved. The MCR/body surface area of hLH was significantly greater in normal men (25.6 plus or minus 3.6 ml/min-m-2) than in normal premenopausal (19.2 plus or minus 0.9 ml/min-m-2) or postmenopausal women (17.4 plus or minus 1.9 ml/min-m-2). No difference was noted in the MCR of hLH in women with oligomenorrhea or amenorrhea. Production rates (PRs) were calculated by using a pituitary standard, the values being 85.1 plus or minus 21.5 IU/24 h in normal men, 39.9 plus or minus 12.6 IU/24 h in normal premenopausal women, and 294.6 plus or minus 61.9 IU/24 h in normal postmenopausal women. The initial half-times of disappearance of the alpha- and beta-subunits of hLH were measured in two normal men and found to be 15-18 min, respectively. The half-time of intact hLH was twice as great.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1170215      PMCID: PMC436562          DOI: 10.1172/JCI108060

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Isolation and properties of human luteinizing hormone subunits.

Authors:  J Closset; G Hennen; R M. Lequin
Journal:  FEBS Lett       Date:  1972-04-01       Impact factor: 4.124

Review 2.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

3.  Luteinizing hormone. 2. Relative reactivities of tyrosyl residues of the porcine hormone towards iodination.

Authors:  Y Combarnous; G Maghuin-Rogister
Journal:  Eur J Biochem       Date:  1974-02-15

4.  Temporal patterns of integrated plasma hormone levels during sleep and wakefulness. II. Follicle-stimulating hormone, luteinizing hormone, testosterone and estradiol.

Authors:  F P Alford; H W Baker; H G Burger; D M De Kretser; B Hudson; M W Johns; J P Masterton; Y C Patel; G C Rennie
Journal:  J Clin Endocrinol Metab       Date:  1973-12       Impact factor: 5.958

5.  A generalized computer program for the treatment of data from competitive protein-binding assays including radioimmunoassays.

Authors:  H G Burger; V W Lee; G C Rennie
Journal:  J Lab Clin Med       Date:  1972-08

6.  A radioimmunoassay for human pituitary luteinising hormone using paper chromato-electrophoresis.

Authors:  H G Burger; J R Oliver; J Davis; K J Catt
Journal:  Aust J Exp Biol Med Sci       Date:  1968-10

7.  Repetitive luteinizing hormone elevations in serum of normal men.

Authors:  H R Nankin; P Troen
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

8.  Separation and partial purification of the protein hormones from human pituitary glands.

Authors:  A S Hartree
Journal:  Biochem J       Date:  1966-09       Impact factor: 3.857

9.  Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women.

Authors:  P O Kohler; G T Ross; W D Odell
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

10.  Human luteinizing hormone in man: studies of metabolism and biological action.

Authors:  J C Marshall; D C Anderson; T R Fraser; P Harsoulis
Journal:  J Endocrinol       Date:  1973-03       Impact factor: 4.286

View more
  6 in total

1.  Pituitary self-priming actions of gonadotropin-releasing hormone. Kinetics of estradiol's potentiating effects on gonadotropin-releasing hormone-facilitated luteinizing hormone and follicle-stimulating hormone release in healthy postmenopausal women.

Authors:  J D Veldhuis; W S Evans; A D Rogol; L Kolp; M O Thorner; P Stumpf
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Relative bioactivity of endogenous luteinizing hormone during superovulation therapy for in vitro fertilization in normal-cycling women.

Authors:  M I Abuzeid; J K Hodges; C R Harlow; M G Hull
Journal:  J Assist Reprod Genet       Date:  1996-09       Impact factor: 3.412

3.  Comprehensive pharmacokinetics of urinary human follicle stimulating hormone in healthy female volunteers.

Authors:  J Y le Cotonnec; H C Porchet; V Beltrami; A Khan; S Toon; M Rowland
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

4.  Metabolic and renal clearance rates of purified human chorionic gonadotropin.

Authors:  R E Wehmann; B C Nisula
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  Metabolic clearance and secretion rates of subunits of human thyrotropin.

Authors:  I A Kourides; R N Re; B D Weintraub; E C Ridgway; F Maloof
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  Metabolic clearance of biologically active luteinizing hormone in man.

Authors:  J D Veldhuis; F Fraioli; A D Rogol; M L Dufau
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.